(NAR) VOL. 11 NO.1 / JANUARY – MARCH 2000
In the light of the new information concerning the safety of the subject drug and upon the recommendation of the National Drug Committee (NDC) of the Department of Health, it is hereby ordered that all drug products containing trovafloxacin shall no longer be registrable.
Furthermore, the registration of all Trovafloxacin (Trovan) products are hereby recalled and cancelled. All stocks in the different drug distribution channels should be withdrawn immediately.
This regulation is issued for the safety and protection of the consumers.
Adopted: 03 Jan. 2000
(SGD.) ALBERTO G. ROMUALDEZ, JR. M.D.
Secretary of Health